EUVIMEDEUVIMED felfedezése
Klinische Studie

Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight

Pinzone, M L Fox, M K Sastry, D M Parenti, G L Simon

Journal of Endocrinological Investigation · 2005-05 · 28 (5) · RC1-RC3

DOI: 10.1007/bf03345372 ↗

At a glance

Klinische Studie in Journal of Endocrinological Investigation, published online on 2014-03-18. Written by Pinzone and 4 co-authors. Institution: Division of Endocrinology and Metabolism, Department of Biochemistry and Molecular Biology, The George Washington University School of Public Health …. Cited 6 times so far (Crossref); 18 references.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

Leptin, the protein product of the obese gene (ob), is secreted by adipocytes. Circulating leptin levels correlate with fat mass in humans, including individuals infected with HIV. Leptin serves as an adipostatic hormone, a permissive factor for reproduction and a modulator of immune function. Leptin is a cytokine, and has been demonstrated to enhance CD4 cell proliferation and IL-2 secretion from CD4 cells in vitro. The role of leptin in HIV-positive patients treated with highly active antiretroviral therapy (HAART) has not been well defined. We haveevaluated leptin levels in HIV-infected individualsduringthe early phase of HAART. We measured plasma leptin levels in 15 antiretroviral-naive HIV positive patients at baseline and after 1 and 4 weeks of HAART. After the first week of therapy, mean leptin level and CD4 count were increased compared to baseline, 6.0 vs 7.2 ng/ml (p = 0.004) and 377 vs 432 cells/ul (p = 0.014), respectively. In contrast, mean body mass index (BMI) remained unchanged 27.0 vs 26.8 kg/m2 (p < 0.08). After four weeks of therapy, leptin and BMI values were unchanged compared to baseline, 6.0 vs 5.9 (p < 0.4) and 27.0 vs 26.9 (p < 0.5), respectively, whereas CD4 count continued to increase to 491 cells/ul (p < 0.012 compared to baseline). These data demonstrate an early transient increase in plasma leptin levels in HIV positive patients initiated on HAART, despite a lack of change in BMI. It is unclear if the transient increase in leptin is related to its role as a cytokine, a metabolic regulator, or reproductive factor.

Subjects

MeSH terms (MEDLINE)

Antiretroviral Therapy, Highly ActiveBody Mass IndexBody WeightCD4 Lymphocyte CountHIV InfectionsHIV SeropositivityHumansLeptin

Substances

Leptin

Authors and institutions

  • Division of Endocrinology and Metabolism, Department of Biochemistry and Molecular Biology, The George Washington University School of Public Health and Health Policy Washington, DC, USA.

Cite

APA

Pinzone, Fox, M. L., Sastry, M. K., Parenti, D. M., & Simon, G. L. (2005). Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight. Journal of Endocrinological Investigation, 28(5), RC1-RC3. https://doi.org/10.1007/bf03345372

Vancouver

Pinzone, Fox ML, Sastry MK, Parenti DM, Simon GL. Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight. Journal of Endocrinological Investigation. 2005;28(5):RC1-RC3. doi:10.1007/bf03345372

BibTeX
@article{Pinzone2005,
  author = {Pinzone and Fox, M L and Sastry, M K and Parenti, D M and Simon, G L},
  title = {Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight},
  journal = {Journal of Endocrinological Investigation},
  year = {2005},
  volume = {28},
  number = {5},
  pages = {RC1--RC3},
  doi = {10.1007/bf03345372}
}
Start for free →